Effect of Pirfenidone on Glomerular Filtration Rate and Albuminuria in Patients With Diabetic Nephropathy
Active, no longer recruiting
Phase of Trial: Phase III
Latest Information Update: 14 May 2018
At a glance
- Drugs Pirfenidone (Primary)
- Indications Diabetic nephropathies; Proteinuria
- Focus Therapeutic Use
- Sponsors Medifarma
- 04 May 2018 Planned End Date changed from 1 Dec 2018 to 1 Dec 2019.
- 04 May 2018 Planned primary completion date changed from 1 Mar 2018 to 1 Mar 2019.
- 04 May 2018 Status changed from recruiting to active, no longer recruiting.